ProPhase Labs Inc (NASDAQ:PRPH) has a beta value of -0.60 and has seen 1.07 million shares traded in the last trading session. The company, currently valued at $12.07M, closed the last trade at $0.40 per share which meant it lost -$0.04 on the day or -8.11% during that session. The PRPH stock price is -1770.0% off its 52-week high price of $7.48 and 45.0% above the 52-week low of $0.22. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.71 million shares traded. The 3-month trading volume is 9.85 million shares.
The consensus among analysts is that ProPhase Labs Inc (PRPH) is Hold stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 1 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.18.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
Sporting -8.11% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the PRPH stock price touched $0.40 or saw a rise of 32.77%. Year-to-date, ProPhase Labs Inc shares have moved -46.60%, while the 5-day performance has seen it change -5.82%. Over the past 30 days, the shares of ProPhase Labs Inc (NASDAQ:PRPH) have changed -9.92%. Short interest in the company has seen 0.79 million shares shorted with days to cover at 0.04.
Wall Street analysts have a consensus price target for the stock at $14, which means that the shares’ value could jump 97.14% from current levels. The projected low price target is $14.0 while the price target rests at a high of $14.0. In that case, then, we find that the current price level is -3400.0% off the targeted high while a plunge would see the stock gain -3400.0% from current levels.
ProPhase Labs Inc (PRPH) estimates and forecasts
The company’s shares have lost -82.19% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 214.08%.
1 analysts offering their estimates for the company have set an average revenue estimate of 2.45M for the current quarter. 1 have an estimated revenue figure of 3.55M for the next ending quarter. Year-ago sales stood 3.63M and 2.47M respectively for this quarter and the next, and analysts expect sales will shrink by -32.58% for the current quarter and 214.08% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -47.90% over the past 5 years.
PRPH Dividends
ProPhase Labs Inc is expected to release its next earnings report on 2024-Nov-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
ProPhase Labs Inc (NASDAQ:PRPH)’s Major holders
Insiders own 11.16% of the company shares, while shares held by institutions stand at 8.62% with a share float percentage of 9.70%. Investors are also buoyed by the number of investors in a company, with ProPhase Labs Inc having a total of 37.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.66 million shares worth more than $2.74 million. As of 2024-06-30, VANGUARD GROUP INC held 3.6351% of shares outstanding.
The other major institutional holder is RENAISSANCE TECHNOLOGIES LLC, with the holding of over 0.22 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.92 million and represent 1.222% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Perritt Funds Inc-Perritt MicroCap Opportunities Fund . As of Dec 31, 2024 , the former fund manager holds about 1.90% shares in the company for having 454.64 shares of worth $0.18 million while later fund manager owns 210.0 shares of worth $84903.0 as of Jan 31, 2025 , which makes it owner of about 0.88% of company’s outstanding stock.
